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Abstract The protein databank now contains the struc-
tures of over 11,000 ligands bound to proteins. These
structures are invaluable in applied areas such as structure-
based drug design, but are also the substrate for under-
standing the energetics of intermolecular interactions with
proteins. Despite their obvious importance, the careful
analysis of ligands bound to protein structures lags behind
the analysis of the protein structures themselves. We
present an analysis of the geometry of ligands bound to
proteins and highlight the role of small molecule crystal
structures in enabling molecular modellers to critically
evaluate a ligand model’s quality and investigate protein-
induced strain.
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Introduction
Structures of protein–ligand complexes determined from
single crystal X-ray diffraction data provide the clearest
snapshots we have of the world of protein structure and
function. Such structures have provided invaluable infor-
mation in the understanding of biochemical processes and
have been used extensively in successful structure-based
drug design campaigns [1].
We referred above to structures—but when we talk
about such structures we are, of course, really discussing
models. It is easy to lose sight of this distinction, but it is an
important one, as correctly interpreting the electron density
in and around the protein binding site is far from being a
straightforward task.
There is considerable evidence that the quality of ligand
models within published X-ray derived protein structures
has, in the past, been rather poor [1–3]. Despite this
problem being well recognised, structures continue to be
published which have obviously incorrect ligand geometry.
For instance, scientists were recently treated to the long
awaited structure of the potential drug target IKKb
(inhibitor of jB kinase b) (Protein Data Bank (PDB) code
3qad, ligand identiﬁer XNM) [4]. However as originally
published, the aminopyrimidine ring of the bound inhibitor
did not have the planar geometry one might expect, raising
doubts over the interpretation of the electron density of this
bound ligand (Fig. 1). Subsequently, after being alerted to
this error, the authors were able to re-reﬁne the structure
and generate the correct aminopyrimidine geometry (PDB
code 3rzf).
The most obvious and understandable reason for errors
in ligand geometry is the limited resolution to which data
can be collected for some systems. The lower the resolu-
tion, the less well deﬁned electron density maps become
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However, another explanation is the failure of protein
crystallographers to discard models with poor ligand
geometry in favour of better ones.
There is a well known idiom in English that ‘a bad
workman blames his tools’ and it is true that geometrical
dictionaries for deriving bond, angle and torsional
restraints for use in reﬁnement do not exist for many
substructures that are found within ligands. Protein crys-
tallographers must therefore create their own tools; good
geometries are unlikely to be obtained without good dic-
tionaries. However, this brings another saying to mind—‘It
is not the tools we use which make us good, but rather how
we employ them’.
It is worth at this point mentioning other factors that
make the crystallographer’s task more difﬁcult. Most fre-
quent is the partial occupancy of a binding site by a ligand.
This problem presents itself with low afﬁnity ligands, such
as the small ligands favoured in fragment-based drug
design, and those with low solubility. Alternatively a
binding site might be fully occupied, but disorder occurs,
the ligand taking up multiple different binding modes. In
very high resolution structures it may be possible to resolve
both binding modes. However this is not possible for low
resolution structures and in such cases it can be difﬁcult to
position a ligand with a good ﬁt to the electron density and
plausible geometry.
Ligand structures with incorrect geometry have the
potential to be highly misleading if used within a drug
design context [5]. Moreover, such protein-ligand com-
plexes may also ﬁnd their way into test sets used for
developing and evaluating molecular modelling software,
for example protein-ligand docking packages [1, 6].
Errors in ligand reﬁnement also confound analysis of the
amount of strain that a protein can impart on a ligand in its
bound state. It is undisputed that enzymes can strain sub-
strates - this is, after all, the mechanism by which some
operate, achieving an enzyme stabilised high energy state
which can then facilitate the required chemical transfor-
mation. Synthetic enzyme inhibitors too can exhibit strain.
Kuntz et al. [7] have observed that, as the size of ligands
increases, afﬁnity often reaches a plateau despite the larger
number of ligand-protein interactions made. This might in
part be due to the energetic compromises, in terms of
internal strain energy, that a large ligand needs to make in
order to still bind to a protein [8, 9]. It may also provide
part of the explanation behind the observation that when
small fragments of inhibitors are chemically linked, the
potency gain achieved is seldom the theoretical maximum
[10, 11].
So there is likely to be some justiﬁcation to claims that
ligands bind to proteins in conformations that are not their
energetic minima [8], but how much strain is generally
tolerated? A study by Perola and Charifson suggested that
over 10% of ligands in a set of 150 abstracted from PDB
models, had strain energies greater than 9 kcal mol
-1 [12].
Hao et al. put an average value of 0.6 kcal mol
-1 strain
energy per torsional motif (i.e. per bond containing that
motif) for nine different common torsional motifs again
using structures drawn from the PDB [13] However, a
more modest maximum strain energy of 3 kcal mol
-1 per
ligand has been suggested by others [14–16]. It also has
been pointed out that current forceﬁelds are unequal to the
task of assessing relative energies for conformers of drug-
size molecules [17]. The data of Perola and Charifson has
recently been critically re-examined [15, 18], and it has
been suggested that alternative low energy conformations
can be found which ﬁt the structural data as well or better
for some of these high energy complexes. It seems perhaps,
that it is not proteins which strain ligands, but protein
crystallographers [1, 19, 20].
What methods exist therefore for the validation of ligand
structures? First of all electron density maps can be used to
visually examine how well a ligand ﬁts the available data.
In recent years deposition of structure factors has become
more prevalent and, in a positive move, the world wide
PDB stipulated in 2008 that structure factors must be
deposited. So it is now in principle possible for any sci-
entist to analyse ligand ﬁt to electron density.
Use of prior knowledge of preferred geometry is another
way to validate ligand geometry and the most compre-
hensive source of appropriate prior information is the
Fig. 1 Unusual
aminopyrimidine geometry in
the ligand in 3qad
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123Cambridge Structural Database (CSD) [21] which contains
structural information on over 500,000 small organic and
metallo-organic molecules. The object of this study is to
use the CSD to attempt an objective review of ligand
structure quality in protein structures, and to establish
whether it is possible to distinguish easily between those
ligands which are likely to be correctly reﬁned but are of
strained geometry, and those ligands that simply exhibit
incorrect geometry. Another object of this study is to see if
the quality of ligand structures had increased over recent
years. Use of a speciﬁc tool for validating the geometry of
ligand models against experimental structures, Mogul [22],
was to be a key component of this work.
Experimental section
Ligand-protein structures chosen for study
Three datasets were selected from the PDB, each con-
taining approximately 100 ligand-protein structures. The
ﬁrst set was selected from structures published before the
year 2000. A starting point was randomly chosen and then
the next 100 PDB codes in alphabetic sequence, which
corresponded to suitable ligand-protein complexes, were
harvested. Those containing duplicate ligands and most of
those containing co-factors were excluded. Also excluded
were covalent ligands. Protein modiﬁcations (such as
N-acetyl glucosamine), small co-solvent molecules and
non-physiologically relevant co-crystal partners were not
classed as ligands for this study. Lastly, if a series of
structures from the same authors was encountered only the
ﬁrst two were used. The second and third sets of structures
were selected in a similar manner from structures published
in 2006 and 2009, respectively. These three lists of PDB
codes are available as Supplementary Information.
CSD ligand structures chosen for study
A list of entries in the CSD for FDA approved drug mol-
ecules was searched to exclude structures with no common
rotatable bonds and with Z0 [1 and number of chemical
residues[1. Structures also had to have an R-factor B0.1,
and not be disordered, or polymeric or present as an ion.
The ﬁnal list numbered 440 entries.
Evaluation tools and procedures
To evaluate structural geometry we used the program
Mogul [22, 23], a module of the Cambridge Structural
Database System (CSDS) (http://www.ccdc.cam.ac.uk).
This is a knowledge-base of molecular geometry which,
given an input structure, compares the bond lengths, bond
angles and dihedral angles of that structure with parameter
distributions derived from of similar substructures.
Recently it has become possible to also analyse rings
geometry in Mogul [33]. Using Mogul any geometric
parameters which are clearly unusual can be located
immediately. Mogul has also been used to help set up
geometric constraints within the context of small molecule
structure reﬁnement in the CRYSTALS (http://cryst.
chem.ox.ac.uk/mogul.html,) and DASH (http://www.ccdc.
cam.ac.uk/support/documentation/dash/doc/portable_html/
dash.1.138.html) packages. As most entries in the CSD are
of atomic resolution they are much less reliant on inter-
pretation and choice of restraints, and for the purposes of
this analysis can be assumed to be correct.
We assume a premise that the statistical distributions
derived from small molecule crystallographic information
are generally applicable to protein-ligand complexes and
other states. This needs some elaboration. The speciﬁc
assumption is; given that a sufﬁciently large sample of rel-
evant chemistry exists in the CSD, then the absence of
experimental values close to the model value implies the
model value represents an unusual geometry and suggests
that signiﬁcant internal or ‘strain’ energy would be incurred
to achieve that geometry. Itdoes not mean that the geometry
is to all intents and purposes inaccessible under standard
conditions as a zero incidence cannot be used to quantify the
internal energy that would need to be incorporated. Allen
et al have published comparisons of CSD distributions with
quantumchemicalcalculations thatprovideevidence forthe
premise [24].
In this work ligands were ﬁrst loaded into the CSDS
module Mercury [25], hydrogen atoms were added where
appropriate and bond and atom types assigned according to
CSD conventions. The Mogul program was then called from
within Mercury. Standard default settings were used. We
examined bond lengths, bond angles, torsional dihedral
angles and non-aromatic ring geometries, butwere primarily
concernedwithidentifyingunusualtorsionaldihedralangles,
foranumberofreasons.First,thenumberofrestraintsneeded
to account for commonly found bond lengths and angles
within ligands is far fewer than those required to account for
commonlyoccurringtorsionaldihedrals,makingitharderfor
reﬁnementprogramstocorrectlytakeaccountofallpreferred
torsions. Secondly, torsional dihedral angle distributions are
frequently multimodal and have wide allowed ranges. Bond
lengths and angles generally have much tighter tolerances
andevenifincorrect,willnotusuallylietoofarfromexpected
values. If one or more torsional dihedral angles are signiﬁ-
cantly wrong this will usually impact the overall molecular
shape much more than having one or more deviant bond
lengths or bond angles. Nevertheless, incorrect bond angles
can be indicative of a poor ligand model, especially if the
incorrect angle is near the centre of a large molecule.
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high strain conformations even if the individual bonds,
bond angles and torsional dihedrals are accurate. A par-
ticular problem can occur when a ring with incorrect
geometry in the initial model (e.g. a boat form cyclohex-
ane) is not converted to the correct model (e.g chair form
cyclohexane) during reﬁnement, even if the data quality is
good. So, non-aromatic ring geometries were also exam-
ined closely.
Mogul is able to identify all the unusual geometric
parameters within a model, returning an assessment of how
unusual a parameter is via an appropriate ﬁgure of merit.
The torsional ﬁgure of merit in Mogul used in this work is
termed the local density measure. This measures the ratio of
incidences in the CSD within 10 of the torsional dihedral in
question, to the number of total incidences of the torsional
dihedral in the CSD. If this ﬁgure was less than 5% we
consider the torsional dihedral to be ‘unusual’. We describe
a ﬁgure of 0% as a ‘highly unusual’ dihedral. It should be
noted that a given torsion (say X1-X2) may be represented
by several torsional dihedrals if X1 or X2 are multiply
substituted. Numerical analyses are based on the number of
incorrect torsional dihedrals. Figures of merit for bond
lengths and angles are the numbers of standard deviations of
the input query parameter from the mean value in the CSD
(z-score). We classed an unusual bond-length or bond angle
as one that is greater than two standard deviations from the
mean (z-score C2). The ﬁgure of merit used for rings was
the average angular RMSD of torsional angles in the ring,
compared with similar average angular RMSDs over all the
rings retrieved by the Mogul search. Ring conformations
were classiﬁed as unusual when less than 5% of the average
angular RMSDs values for the hits were within 10 of the
average angular RMSD in the query.
Our ability to distinguish good from bad geometry is
dependent on the number of examples available for the
substructure under study. Where insufﬁcient examples
were available, no assessment was made. We decided that
at least 5 examples were required for bonds and bond
angles to be assessed and at least 15, for torsional dihe-
drals. Using these criteria less than 1% of all geometric
features were insufﬁciently populated to allow an assess-
ment. In most cases the number of hits available signiﬁ-
cantly exceeded the acceptance minima.
Asthebondandanglecriteriafor‘unusualness’arebased
onatwostandarddeviationcriterion,itcouldbearguedthere
should be a natural error rate of 5% in an ‘average’ structure
in the CSD. One could extend this reasoning to the torsional
information as well, although perhaps less convincingly. To
make conservative allowance for this we decided that an
error rate of at least 10% for any single type of geometric
feature (i.e. bond, angle or dihedral) was generally the
minimum requirement to class a ligand as having unusual
geometry. Exceptions were made for cases where a single
geometric feature was very signiﬁcantly non-standard; such
ligands were also classed as having unusual geometry.
Conversely, where several geometric features of a single
type were borderline unusual, the ligand was not generally
classiﬁed as having unusual geometry.
Other factors required evaluation before we could
attempt to classify ligands with unusual geometry to either
having been incorrectly reﬁned, or to possibly being
strained. The binding site of the protein in question was
examined using the program Relibase?,[ 26] a tool
designed for analysing protein-ligand interfaces. We noted
(a) how well buried any substructure was within the pro-
tein, (b) how many stabilising interactions the ligand made
with the protein and surrounding water networks, and
(c) the contacts between protein and ligand or intramo-
lecularly within the ligand. Whenever possible, we used the
Electron Density Server at Uppsala University to visually
check the ﬁt of each ligand to the experimental electron
density [27]. Whilst this could be done for many of the
structures from the 2006 list and almost all of the structures
from the 2009 list, only a few of the pre 2000 list had
structure factors deposited.
With all these observations in hand, ligands were put
into one of three classes; ‘OK’ (i.e. no unusual geometry
that would alter the interpretation of the binding mode),
‘Strained?’ (i.e. unusual geometry but could be correctly
reﬁned) and ‘Questionable’ (i.e. unusual geometry likely
due to poor reﬁnement). Because this classiﬁcation process
is somewhat subjective, it was important to only categorise
structures into the third category if the cumulative evidence
was overwhelmingly strong that the structure was poorly
reﬁned. We collected additional information for the subset
of structures submitted in 2006, viz: (a) the resolution of
the structure, (b) the number of heavy atoms, (c) the
number of non-terminal rotatable bonds, and (d) the pro-
portion of ‘unusual’ geometric features found for each of
the three geometric feature classes: bonds, bond angles and
torsional dihedrals. A one-tailed, non-paired Student’s T
test was carried out for each pair of populations out of
‘OK’, ‘Strained?’ and ‘Questionable’ to identify whether
they could be deﬁnitively separated according to criteria
(a), (b) and (c).
Results and discussion
The result of the analysis process was to assign ligands into
one of three classes; ‘OK’ (i.e. no unusual geometry that
would alter the interpretation of the binding mode),
‘Strained?’ (i.e. unusual geometry but could be correctly
reﬁned) and ‘Questionable’ (i.e. unusual geometry likely
due to poor reﬁnement). It has already been stated that this
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tures were only put into the third category if the cumulative
evidence was overwhelmingly strong that the structure was
poorly reﬁned. A number of structures in the ‘Strained?’
category are likely to be incorrect, but we could not cate-
gorise them so with absolute certainty. In addition, we
decided to class structures as ‘OK’ if serious deviations
from normal geometry did not affect the overall interpre-
tation of the binding mode, but we noted them and we will
return to this set.
Simple statistics
The ﬁrst notable result is that the number of structures
deemed likely to be incorrectly reﬁned, is a substantial
proportion of all three subsets, at 20–25%, with a small, but
statistically insigniﬁcant decline over time (Fig. 2). The
second result of note is that the set of ‘Strained?’ structures
submitted prior to 2000, is much larger than for the 2006
and 2009 subsets. This is entirely a consequence of the lack
of electron density information available to us for most of
these structures, which prevented a clearer classiﬁcation
being made. Had this information been available, it is
likely that more of the pre-2000 ligand structures would
have been classed as ‘Questionable’. Consistent with this
view is the observation that the number of structures hav-
ing ‘OK’ geometry is much lower for the pre-2000 subset.
Ligand classiﬁcation, structural complexity
and geometric feature types
Table 1givesmeansandstandarddeviationsforanumberof
different ligand characteristics in the 2006 set divided into
the three classiﬁcations of ‘OK’, ‘Strained?’ or ‘Question-
able’. A one-tailed, non-paired Student’s T test was carried
out for each pair of populations to identify whether they
could be deﬁnitively separated according to the respective
criteria. We also present histograms to reveal how classiﬁ-
cationdependsonresolutionandligandcomplexity(Fig. 3).
The T test indicates that no strong relationship exists
between classiﬁcation and the resolution of the structures.
Figure 3a conﬁrms this, although it is important to point out
that ligands from extremely high resolution structures
(\1.3 A ˚) usually have good ligand geometries, perhaps
because the data is sufﬁcient to reﬁne to atomic resolution.
Clear errors found in three slightly higher resolution struc-
tures (1.3–1.5 A ˚) are obvious and correctable mistakes that
should have been picked up by inspection (i.e. very unusual
bond lengths and angles for 2fgv and 2grb and a misinter-
pretation of electron density in 2cl2 that is discussed later).
Conversely, ligand complexity, as determined simply by
number of heavy atoms or number of rotatable bonds, does
depend on whether a ligand is classed as good or not. The
‘OK’ class of ligands is clearly separated from the
‘Strained?’ and the ‘Questionable’ classes with [95%
conﬁdence in both cases. It is not possible to separate the
‘Strained?’ and the ‘Questionable’ classes in this way.
Ligands with less than 20 heavy atoms or with no rotatable
bonds are usually reﬁned without signiﬁcant geometric
error.
Fig. 2 Classiﬁcation of ligands according to structural geometry for
samples of protein/ligand structures submitted to the PDB at different
times
Table 1 Statistical data on each ligand class for attributes of the ligand structure and the resolution of the protein model; and P values for
rejecting the null hypothesis, that the attribute does not distinguish between pairs of classes (signiﬁcant comparisons in bold)
Category n Resol. (A ˚) Heavy atoms No. torsions %Bonds
‘unusual’
%Angles
‘unusual’
%Dihedrals
‘unusual’
Mean (SD)
OK 43 2.1 (0.5) 22.1 (12 4.7 (5) 22.0 (24) 16.9 (14) 7.5 (17)
Strained? 38 2.04 (0.37) 34.5 (21) 8.9 (6) 20.4 (20) 19.7 (13) 22.7 (20)
Questionable 24 2.14 (0.42) 30.1 (18) 8.3 (7) 26.5 (19) 24.5 (14) 21.0 (17)
P value
OK/Strained? 0.3975 0.0006 0.0004 0.3755 0.1749 0.0003
OK/Quest. 0.2692 0.0149 0.0112 0.2165 0.0194 0.0016
Strained?/Quest. 0.1577 0.2009 0.3337 0.1203 0.0852 0.3605
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analysis. The histograms also appear to show that there is a
signiﬁcant and counterintuitive difference between the
‘Strained?’ and the ‘Questionable’ sets in that a much
greater proportion of the ‘Strained?’ set, are of high com-
plexity. This is an artefact of the conservative application
of the ‘Questionable’ classiﬁcation in this work. Many of
the larger ligands in the ’Strained?’ set may in fact be non-
optimally reﬁned and therefore in principal assignable to
the ‘Questionable’ category. However, because it is hard to
say with certainty that this is so for individual cases, many
of these structures were given the beneﬁt of the doubt.
There is an inference from this that the actual number of
poorly modelled ligands is signiﬁcantly more than the 25%
conservatively claimed here.
For completeness we now look at how our ligand classi-
ﬁcationdependsongeometricfeatureclassiﬁcation.Noneof
the three classes can be separated from each other with ref-
erence to bond geometry only. By contrast, the torsion error
rate can clearly be used to distinguish ‘OK’ from both
‘Questionable’ and from ‘Strained?’ structures. This is
entirelyexpectedasitwasthemajorcriterionusedtoidentify
the‘OK’structuresintheﬁrstplace.Ofmoreinterestisthata
low bond angle error rate can also be used to identify ‘OK’
structures from ‘Questionable’ structures. It cannot be used
to identify ‘OK’ structures from ‘Strained?’ structures.
Errors in incorrectly reﬁned ligands
Bonds and angles
One clear observation is that many bond length and bond
angle errors are found in structures that were classiﬁed as
‘OK’. However, as already noted, substitution of the correct
bond lengths or bond angles would not, on minimisation of
the structure, lead to a different interpretation of the binding
mode. Nevertheless they do represent true reﬁnement errors
and point to incorrect ligand dictionaries being employed in
the reﬁnement. Over 70% of the ligands in the 2006 set were
found to have errors over bond length and bond angle fea-
tures of greater than 10%. Of the 30 or so ligands which did
not show such errors, four were peptidic ligands, and three
were saccharides. It is perhaps unsurprising that good dic-
tionaries do exist for these types of ligand.
In some of cases errors are extraordinarily large, sufﬁ-
ciently so as to put these models in the ‘Questionable’
category. For instance the pyrollidine carboxamide inhib-
itor of enoyl reductase (PDB 2h7 m, ligand ID 641) has a
Fig. 3 Breakdown of each class a according to resolution of the protein structure; b according to the number of heavy atoms in the ligand,
c according to the number of non-terminal rotatable bonds in the ligand
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123C–N bond length 0.946 A ˚, 23 standard deviations from the
bond length in similar structures (Fig. 4a). Sulphur-oxygen
and phosphorous-oxygen bonds appear to be particularly
poorly treated, e.g. in 2hwh (ligand ID RNA), the sulph-
onamide S=O bonds are elongated, such that they lie 14
standard deviations from normal geometry (Fig. 4b).
Although in most cases bond and angle errors do not
change the interpretation of the ligand binding, this is not
always true. A highly abnormal bond angle (C12–C13–N)
associated with the 1,2,3-triazole in the ligand (H7J, chain
A) in 2hxz is 14 standard deviations from ideal (Fig. 4c).
The chain B and C ligand models in 2hxz have more rea-
sonable C12–C13–N bond angles though they are still 3 SD
from ideal. Large errors in bond angle assignment in a
Fig. 4 Severe deviations from
normal bond and angle
geometry: a extremely short
bond in 2h7 m ligand;
b extremely long S=O bonds in
2hwh ligand; c Very tight
C=C–C bond angle in 2hxz
ligand
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difﬁculty in ﬁnding reasonable placements for the periph-
eral parts, because of leverage.
Torsion angles
Highly unusual bonds and bond angles can easily be identi-
ﬁed by reference to the distributions in the CSD. The dis-
tributions of torsion angles are often more complex and our
deﬁnitionof‘unusual’needsalittlemorethought.However,
there are many simple cases where a dihedral angle distri-
bution may have a small number of very sharp maxima,
implyingthatthetorsionalenergybarrieristoohightoallow
non-standard values. Perhaps the best example is that of
amide bonds, where clear preferences exist in the CSD.
Despite this we often see unusual amide torsions in ligands
boundtoproteins.Astrikingexampleistheglycosidicligand
in endo-1,3-beta glucanase (2cl2, ligand ID BMA). This
structure is of very high resolution, 1.35 A ˚, and visual
inspectionofelectrondensitymapswouldsuggestthatishas
beenwellreﬁned,withthelarge,ﬂexibleligandﬁttingwellto
the electron density (Fig. 5). However two amide bonds in
the ligand are set as cis rather than trans for no obvious
reason. This results in a short internal CH3   OH contact of
2.86 A ˚ for one of them. The alternative trans orientations of
the amides are almost isoelectronic, would ﬁt the electron
density equally well, and would replace this unlikely short
contact with a good C=O   OH hydrogen bond.
Amide bonds and similar torsions aside, many propensity
histograms of torsional dihedrals show broad and multi-
modal maxima, implying a relatively low energy difference
between rotamers. Observations that a small proportion of
dihedrals for a given ligand, are lying in the less populated
regions of the distribution might well be an indication of
conformational strain. However for ligands where a large
proportion of dihedrals are classiﬁed as unusual it is a strong
indication that reﬁnement error exists. Figure 6a shows the
breakdown of each class of ligands according to percentage
of torsional errors. The proportion of unusual torsional di-
hedrals in ‘Questionable’ structures is usually in excess of
20%. The proportion of unusual dihedrals in the ‘Strained’
set is also high, suggesting once more that a number of these
do in fact represent poor models. Figure 6b, by contrast
shows the breakdown of unusual torsional dihedrals in a set
of 440 FDA approved molecules (i.e druglike molecules)
for which crystal structures exist in the CSD. 90% of the
structures show no unusual dihedrals at all and the overall
distribution is similar to that of the ‘OK’ set in Fig. 6a.
Ring systems
All ligands containing rings of unusual geometry auto-
matically were classiﬁed as ‘Strained?’ or ‘Questionable’,
irrespective of other geometric features. Of the thirteen
ligands in the ‘Strained?’ set that contained non-aromatic
rings, six showed ring geometry errors. There are also
thirteen such ligands in the ‘Questionable’ class, of which
ﬁve have unusual ring geometry.
Highly unusual ring geometries, like torsions, are not
necessarily indicative of an error, however further
Fig. 5 Incorrect cis amide bond geometries (highlighted)i na n
otherwise high quality ligand structure (2cl2)
Fig. 6 a Breakdown of each ligand class according to percentage of unusual dihedrals. b Breakdown for a set of 440 CSD structures of FDA
approved molecules
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123examination may reveal that an error exists. The sugar of
hexyl-beta-D-glucoside bound to human glycolipid transfer
protein 2evs (ligand ID GLC) (2.2 A ˚ resolution), differs
signiﬁcantly from normal geometry (Fig. 7a, left). As this
ring also has several implausible bond angles and there are
other unusual torsions within this ligand it is clearly in error.
However, this is not evident from assessing the ﬁt of this
ligand to electron density maps alone. This example is a
particularly good illustration of the value of tools for
assessing ligand geometry, especially in cases where the
structure is only determined at modest resolution. This
structure was found to be originally generated using the
incorrect a-anomer. and has since been re-reﬁned using the
correct b-anomer, with a more plausible geometry (Fig. 7b,
right) [33].
Treatment of disorder and multiple occupancy
It is common to see only a partial occupancy of a binding
site by a ligand in a protein crystal structure [1, 3]. This
may reﬂect disorder or even two equally low energy
binding modes for the ligand [9]. Difﬁculties in appropri-
ately modelling the complex electron density, which may
represent a mixture of solvent and ligand molecules,
potentially in multiple conformations, do make it easy to
allow geometrical errors to creep in.
We identiﬁed many implausible geometric features in
regions of ligands that did not produce easily interpretable
electron density. Most often errors are seen in pendant
groups attached to the rest of the ligand by a single bond. A
good example is the thrombin inhibitor ligand in 1ae8
(ligand ID AZL) (resolution 2.00 A ˚) (Fig. 8a). The N9-
C23-O24-C24 carbamate dihedral is well represented in the
CSD and the distribution is sharp, implying distinct pref-
erences for this system. This ligand is, however, modelled
with an angle not observed in the small molecule structures
in the CSD. There is no observable electron density for this
group, which does not contact the protein and it is difﬁcult
to provide scientiﬁc justiﬁcation for such unusual geome-
try. Clearly, any arguments relating to ‘proteins straining
ligands’, are not appropriate here.
Where the resolution of crystal structure is reasonably
high it is possible to identify multiple binding modes for a
ligand to a protein. Our selected structures contain seven
such cases (PDB codes 2hs1, 2i0h, 2b60, 2f3k, 2ij7, 3dtx,
3fwa), all in the 2006 and 2009 sample sets. If we make the
assumption that this proportion is representative of struc-
tures in the entire PDB then at least 2% of all protein-
Fig. 7 Although the ligand in 2evs (2.2 A ˚ Resolution) apparently ﬁts the e.d. the ring geometry is poor (a). Re-reﬁnement leads to similar
quality structure with much improved ring geometry (b)
J Comput Aided Mol Des (2012) 26:169–183 177
123ligand complexes might be expected to show multiple
binding modes. In fact the ﬁgure is likely to be larger than
this because we could reasonably argue that multiple-
occupancy has been missed in the structures with low
resolution, and may well not have been picked up in
structures submitted pre-2000.
Even when electron density is interpreted as represent-
ing ligands binding in multiple modes it remains difﬁcult to
model ligands. The structure 2i0 h (ligand ID 222) (reso-
lution 2.0 A ˚) illustrates this well (Fig. 9a). Although two
slightly different binding modes have been modelled there
are many implausible bond angles and torsional dihedrals;
neither of the ligand models is likely to be correct. One
might speculate that an alternative ligand binding mode
might ﬁt the electron density equally well, without the need
to model a ligand with unusual geometry and to postulate
two distinct binding possibilities.
The structure of the berberine bridge enzyme, 3fwa
(ligand ID REN) (resolution 1.5 A ˚) is an interesting case
for which the resolution does appear to be high enough to
resolve multiple alternative binding modes of the ligand
reticuline (Fig. 9b). We classify this ligand as ‘Strained?’
because the aromatic OMe torsion is unusual in both
placements. Such systems are invariably planar in struc-
tures of small molecules yet are often found out-of-plane in
PDB ligand structures. We concur with Brameld et al. [28]
that most of these occurrences are electron density ﬁtting
errors, but in this case a closer examination is warranted.
The methyl group ﬁts well to a deﬁned pocket of the
protein and it is difﬁcult to postulate an alternative con-
formation. This may well be a true example of a ligand that
can only bind to this target in a conformation that is
strained; although the possibility that alternative binding
modes could be ﬁtted to the electron density cannot be
ruled out.
Can we identify torsional strain?
So it is becoming evident that separating ‘strain’ from
‘error’ is a non-trivial task. For all but the highest resolu-
tion structures, there is a signiﬁcant probability that one or
more unusual torsion angles or other features could be
mutually tweaked to more plausible values by careful re-
reﬁnement. Let’s return to the peptidic thrombin inhibitor,
Fig. 8 Thrombin inhibitor structure 1ae8 a analysis of the carbamate geometry, b analysis of O=C–N–N (O8 C8 N7 N6) dihedral. This and two
other dihedral angles of unusual geometry are highlighted on the 1ae8 ligand structure
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1231ae8 (ligand ID AZL) (2.00 A ˚). This has an O8–C8–N7–
N6 hydrazide dihedral angle value which is not represented
by the small molecule crystal structures CSD (Fig. 8b).
The hydrazide torsion is central to the ligand and appears
within a well deﬁned area of electron density. It might be
considered that there is no need to further improve the
geometry of this part of the molecule, however altering this
angle by a mere 12 places it within a well populated
region of the CSD dihedral distribution. There seems no
reason why corrected dihedral would not be well accom-
modated by the electron density and it would also allow the
pendant alkyl amino chain, which also has two unusual
dihedral angles, to be modelled rather differently (Fig. 8b).
This structure has in fact been recently re-reﬁned to gen-
erate a ligand structure with fewer geometry errors (Per-
sonal communication: Dr Oliver Smart.)
This leads to the conclusion that we should consider
only the highest resolution structures if we wish to clearly
identify strain. Tellingly, almost all of the very highest
quality structures of our 2006 test set were classiﬁed as
‘OK’. Six out of seven have no unusual dihedral angles,
indicating that no signiﬁcant torsional strain is present in
these ligands. Let’s look at some of these structures in
more detail. The structure of a mutant of HIV protease,
with the bound ligand darunavir, 2hs1 (ligand ID O17) has
the highest resolution (0.84 A ˚) of all structures examined
[29]. The ligand is a peptomimetic with 13 rotatable bonds,
so has ample chance to exhibit torsional strain (Fig. 10a).
Two binding modes with opposite orientations are identi-
ﬁed in the symmetrical binding site, with a 3:2 preference
for one orientation. It has already been noted that multiple
binding modes creates problems for good ligand model
building. Despite this it is notable that whilst 9% of bonds
and 14% of bond angles are marked unusual (a failure of
the ligand dictionaries used perhaps?) not a single dihedral
angle in either structure is so identiﬁed. Moreover the
geometry found in the models often corresponds to a
maximum in the dihedral frequency histogram. It is to the
credit of the authors of this work that it has been possible to
create models for two binding modes of this highly ﬂexible
ligand, neither of which are signiﬁcantly strained.
There do exist dihedrals in 2hs1 which have non-optimal
values. Where sufﬁcient data in the CSD exists ([700 hits)
it is possible to make a crude estimate of strain for a given
Fig. 9 Cases where there is double occupancy: a The CSD distri-
bution of the C-Car-Nar bond angle (C15 C16 N21) in the 2i0 h
ligand modelled for double occupancy. This, at 142.88, is extremely
distorted from normal geometry. Other unusual geometric features are
labelled in the left-hand image; b the CSD distribution of the CC-
OMe (C7 O6 C5 C8) dihedral highlighted on the ligand from 3fwa.
This, at 103.448, is signiﬁcantly distorted from normal in both ligand
placements
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the ratio of histogram bar heights at the maximum (hmax)
and at the query values (hquery) and then using these in the
Gibbs free energy equation, DG =- RTln(hmax/hquery).
The dihedral which shows the most pronounced deviation
from standard geometry is C33–C32–C38–C19 (Fig. 10a).
The estimate of strain energy in this torsion comes to about
0.5 kcal mol
-1; an energy penalty to binding that would
reduce the afﬁnity of the compound by about twofold. If
this is an estimate of the torsional strain for one of the most
strained torsions in this ligand then it follows that the strain
per bond over the whole ligand is considerably lower.
The structure of the human aldo-keto reductase, 1zua
(1.25 A ˚), with tolrestate (ligand ID TOL) bound, is another
high resolution structure with good ligand geometry
(Fig. 10b) [30]. The thioamide chemistry is unusual and is
represented hardly at all in the CSD. However, the small
molecule crystal structure of a close analogue of tolrestate
is available (Refcode CAKWAM). The match of the values
of the dihedrals for the three torsions of thioamide is almost
exact between the PDB and CSD models (maximum
deviation over all possible dihedrals is 6.38, minimum
deviation is 0.6, Fig. 10b). The authors do not state that
they referred to this structure in setting appropriate
reﬁnement restraints or building an appropriate starting
model for tolrestate, presumably because the data quality
was good enough that this was not necessary. The agree-
ment in thioamide geometries is therefore remarkable.
Clearly there is negligible protein-induced torsional strain
in this ligand.
Finally, we’ll look at two examples of ligands bound to
proteins where the deviations from standard geometry are
likely to be because of conformational strain. The ligand)
in the aminotransferase structure 1ajs (ligand ID PLA, is a
Fig. 10 Highresolutionstructures:aTheCSDdistributionforatypical
non-optimum dihedral(C33C38C32C19)intheligand fromtheultra-
high resolution structure 2hs1; b the electron density ﬁt and molecular
structure for tolrestat in 1zua. The three dihedrals highlighted have
chemistry which is matched by only one CSD entry, CAKWAM.
However the geometrical correspondence is exact between 1zua and
CAKWAM for these three dihedrals
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123covalent adduct of the cofactor NAD and 2-methylaspar-
tate (determined to 1.6 A ˚ resolution) (Fig. 11a). The
adduct has no fewer than 9 unusual dihedrals according to
our analysis, representing three torsions in total; we
therefore classiﬁed it as ‘Strained?’. The unusual dihedrals
are highlighted in Fig. 11a alongside the CSD distribution
for one of the well represented dihedral angles. Visual
inspection of electron density maps shows a good ﬁt of the
ligand.
In this particular case the six polar groups in the ligand
all make numerous hydrogen bonding interactions with
residues in the active site. No unfavourable contacts are
made. The interactions with the aspartate carboxylates and
the phosphate of the ligand are likely to contribute signif-
icantly to the enthalpy of binding. Clearly there appears to
be torsional strain in this structure but the mechanism by
which this can be offset is also evident. The authors of this
structure point out that structure of the complex differs
from unliganded structure, with a surface loop of hydro-
phobic groups on the N-terminal helix becoming buried.
This entropy-driven process and the interactions between
ligand and protein therefore provide sufﬁcient free energy
to compensate for the unfavourable conformation of the
ligand and drive the formation of the cofactor—methylas-
partate aldimine complex [31].
Our second example is a penta-N-acetyl glucosamine
bound within a thermostable chitinase from pyrococcus
furiosus (3a4w (ligand ID NAG) (1.8 A ˚). This structure
was not one of our three hundred randomly selected
complexes, but is included as it illustrates a number of
points very well. The central six-membered ring of the
ligand is in boat form and our Mogul
22 generated histogram
clearly indicates that similar geometry is not found within
the CSD (Fig. 11b). The ﬁt of the ligand to the electron
Fig. 11 Structures of substrates or analogues: a The NAD-methylaspartate conjugate from 1ajs. Three dihedrals are highly strained (CSD
distribution is shown only for the C–O–P–O dihedral); b Penta-NAG bound in chitinase. The central unit takes up an unusual boat form
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123density is good. It seems that in this case, the four N-acetyl-
glucosamine units all make favourable steric interactions
and hydrogen bonds with the protein and that the free
energy this provides brings about the chair-to-boat con-
version in the central ring.
The ever present possibility of non-optimal reﬁnement
means that a rigorous analysis of strain energy in bound
ligands is challenging. Careful analysis is required to reveal
how much ligand strain energy can be compensated for by
interactions with a protein. Nevertheless, our analysis
suggests that the average torsional strain in ligands that are
inhibitors rather than substrates (or substrate mimics) is
probably much less than previous estimates of 0.6 kcal -
mol
-1 per torsion [13]. Substantial strain is only likely to
be seen in structures where an enzymatic intermediate has
been captured within the protein binding site.
Conclusions
This analysis set out with a primary aim of assessing model
quality for ligand structures in protein crystal structures;
and a secondary aim of investigating the amount of tor-
sional strain energies in protein bound ligands that can be
compensated for by the other components of free energy of
binding.
We found that the geometries of a large proportion of a
sample of 300 recently determined protein-bound ligands
are not consistent with geometries seen within small mol-
ecule crystal structures and that some of this inconsistency
is due to reﬁnement error.
An estimated 70% of the recently determined structures
of protein bound ligands have bond length and bond angle
errors that could be removed by use of better restraint
dictionaries. At least 25% of recently determined struc-
tures, it is estimated, have geometric errors that could have
been caught during crystallographic reﬁnement and are
large enough to potentially lead to a misleading interpre-
tation of the binding interactions.
Error rates are not found to correlate straightforwardly
with the resolution of the structure. However the highest
resolution structures (resolution \1.3 A ˚) do not usually
have unusual ligand geometries. One might have expected
ligands modelled in lower resolution structures to have
near ideal geometry in regions not contacting the protein;
the less data there are available, the less justiﬁcation there
is for postulating unusual ligand geometry. As this is not
the case it is clear that appropriate restraints are not being
applied during the reﬁnement of some ligands.
Although ligands in structures submitted prior to 2000
appear to be the most error prone, we found little evidence
to suggest that quality of ligand geometry has improved
since 2006. Whilst this may be so we point out the Protein
Databank organisations well recognise the issues reported
here and are currently developing tools that will allow
users to check their ligand structures against CSD standard
geometries prior to submission [34].
In addition a bulk re-reﬁnement of PDB structures has
been carried out in an effort to correct many reﬁnement
errors by Joosten et al. [32]. A number of the unusual
geometries explicitly mentioned above, which appear cor-
rectable via rather small atomic position adjustments (e.g.
2h7m, 1ae8, 2i0h) are in fact signiﬁcantly improved in the
PDB_REDO database. Cases where there is an intrinsic
error in the ligand model which requires a signiﬁcant and
concerted atomic movement to correct (as in 2cl2 and 2evs)
are not improved.
Frequent incidence of errors in ligand geometry mean
that efforts to evaluate the ligand strain that can be
accommodated when binding to a protein are fraught with
difﬁculty. We recommend that only the very highest
quality protein-ligand structures be used for such studies.
Where this criterion is met, we see evidence that, for a
ligand that is a highly potent and is not a substrate or
substrate derivative, ligand strain energy is considerably
lower than some commentators have previously suggested
[12, 13]. More work is needed however.
This study highlights the need for greater attention to be
directed towards ensuring good ligand geometry during
electron density interpretation and structure reﬁnement.
The message for the molecular modeller is that careful
validation of ligand geometry and ﬁt to electron density is
an essential preparation for any modelling work based on a
protein-ligand structure. Tools such as the Electron Density
Server [27] and Mogul [25] are available to make this a
relatively simple task.
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